The efficacy of prophylactic <font color="red">ondansetron_2</font> <font color="red">,_2</font> <font color="red">droperidol_2</font> <font color="red">,_2</font> <font color="red">perphenazine_2</font> <font color="red">,_2</font> and <font color="red">metoclopramide_2</font> in the prevention of nausea and vomiting after major gynecologic surgery . 
<br>
<br> The prophylactic antiemetic efficacy of intravenous ( i.v . ) <font color="red">ondansetron_2</font> <font color="red">,_2</font> <font color="red">droperidol_2</font> <font color="red">,_2</font> <font color="red">perphenazine_2</font> <font color="red">,_2</font> and <font color="red">metoclopramide_2</font> was evaluated in a prospective , double - blind study of 360 ASA physical status I - III patients undergoing total abdominal hysterectomy ( TAH ) . Subjects were randomized to receive i.v . , one of <font color="red">ondansetron_2</font> 4 mg , <font color="red">droperidol_2</font> 1.25 mg , <font color="red">perphenazine_2</font> 5 mg , <font color="red">metoclopramide_2</font> 10 mg , or <font color="red">placebo_2</font> prior to induction of anesthesia . Hypotension immediately after administration of <font color="red">metoclopramide_2</font> was observed in two patients and four patients given <font color="red">ondansetron_1</font> developed profound systolic hypotension at induction of anesthesia . Twenty - two percent of patients receiving <font color="red">droperidol_1</font> became sedated . Postoperatively , patients developing severe nausea , retching , or vomiting , defined as severe emetic sequelae ( SES ) , were deemed to have failed <font color="red">antiemetic_1</font> <font color="red">prophylaxis_1</font> and received antiemetic rescue . A significantly larger number of patients who received i.v . <font color="red">ondansetron_2</font> ( 63% ) , <font color="red">droperidol_2</font> ( 76% ) , and <font color="red">perphenazine_2</font> ( 70% ) were free of SES when compared to <font color="red">placebo_1</font> ( 43% ) ; P < 0.05 . <font color="red">Metoclopramide_2</font> was ineffective . Although <font color="red">ondansetron_2</font> <font color="red">,_2</font> <font color="red">droperidol_2</font> <font color="red">,_2</font> and <font color="red">perphenazine_2</font> were effective in providing antiemetic prophylaxis , only i.v . <font color="red">perphenazine_2</font> was free of side effects . Hence , we conclude that <font color="red">perphenazine_2</font> is the best choice for <font color="red">antiemetic_1</font> <font color="red">prophylaxis_1</font> after TAH .